New research shows a drug candidate's potential to combat liver disease and atherosclerosis effectively in nonhuman primates.

Learn how AI in drug discovery is revolutionizing therapeutic development and addressing challenges in cell and gene therapy.

Explore the future of knowledge graphs and their role in scientific discovery, particularly in drug discovery advancements.

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

McGill University researchers have found that two drugs can eliminate senescent “zombie cells” in spinal discs, offering a potential new treatment for chronic low back pain. Research conducted at ...

Researchers at Keio University have developed long-lasting, functional human liver organoids from frozen hepatocytes, marking a huge moment in organoid science. In typical lab conditions, hepatocytes, ...

Researchers in Norway have identified a promising oral drug combination that may stop the replication of enteroviruses, a group of viruses responsible for illnesses ranging from the common cold to ...

McGill University researchers have found that two drugs can eliminate senescent “zombie cells” in spinal discs, offering a potential new treatment for chronic low back pain.

A new study by Scripps Research reveals that apremilast, an FDA-approved anti-inflammatory drug, may help reduce both alcohol consumption and pain sensitivity, offering a potential dual therapy for ...